Compare · EWTX vs PEPG

EWTX vs PEPG

Side-by-side comparison of Edgewise Therapeutics Inc. (EWTX) and PepGen Inc. (PEPG): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both EWTX and PEPG operate in Biotechnology: Pharmaceutical Preparations (Health Care), so they compete in similar markets.
  • EWTX is the larger of the two at $4.51B, about 12.2x PEPG ($370.4M).
  • Both names hit the wire about 12 times in the past 4 weeks.
  • EWTX has more recent analyst coverage (17 ratings vs 6 for PEPG).
MetricEWTXPEPG
Company
Edgewise Therapeutics Inc.
PepGen Inc.
Price
-
-
Market cap
$4.51B
$370.4M
1M return
-
+39.26%
1Y return
-
-26.27%
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Exchange
NASDAQ
NASDAQ
IPO
2021
2022
News (4w)
12
12
Recent ratings
17
6
EWTX

Edgewise Therapeutics Inc.

Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. It offers a precision medicine muscle platform that generates programs to address various muscle disorders, such as Duchenne, Becker, and limb girdle muscular dystrophies. The company develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was founded in 2017 and is headquartered in Boulder, Colorado.

PEPG

PepGen Inc.

PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is also developing PGN-EDODM1, an EDO peptide-conjugated PMO for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.

Latest EWTX

Latest PEPG